Plant Advanced Technologies SA (EPA:ALPAT)
5.15
-0.05 (-0.96%)
Jun 24, 2026, 9:03 AM CET
EPA:ALPAT Market Cap
EPA:ALPAT has a market cap or net worth of €5.83 million as of June 23, 2026. Its market cap has decreased by -48.41% in one year.
Market Cap
5.83M
Enterprise Value
9.52M
Revenue
1.97M
Ranking
n/a
PE Ratio
14.86
Stock Price
€5.15
Market Cap Chart
Since August 5, 2009, EPA:ALPAT's market cap has decreased from 6.22M to 5.83M, a decrease of -6.22%. That is a compound annual growth rate of -0.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 5.83M | -36.59% |
| Dec 31, 2025 | 9.20M | -30.22% |
| Dec 31, 2024 | 13.18M | 43.55% |
| Dec 29, 2023 | 9.18M | -36.37% |
| Dec 30, 2022 | 14.43M | -28.63% |
| Dec 31, 2021 | 20.23M | -10.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| genOway Société anonyme | 21.67M |
| GenSight Biologics | 20.09M |
| Advicenne | 15.83M |
| Aelis Farma | 13.60M |
| Poxel | 11.18M |
| NFL Biosciences | 10.39M |
| Aton | 9.44M |
| TME Pharma | 6.90M |